Stefan Lethagen

A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)

Alberto Tosetto, Francesco Rodeghiero, Giancarlo Castaman et al. · Journal of Thrombosis and Haemostasis · 2006 · 527 citations · Full text

Medicine, Hematology, Pathology +16

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

Anne Goodeve, Jeroen Eikenboom, Giancarlo Castaman et al. · Blood · 2006 · 400 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study

Francesco Rodeghiero, Giancarlo Castaman, Alberto Tosetto et al. · Journal of Thrombosis and Haemostasis · 2005 · 357 citations

Medicine, Hematology, Pathology +16

Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

Pratima Chowdary, Stefan Lethagen, Ute Friedrich et al. · Journal of Thrombosis and Haemostasis · 2015 · 220 citations · Full text

Pharmacy, Immunology, Pharmacokinetics +13

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD

Giancarlo Castaman, Stefan Lethagen, Augusto B. Federici et al. · Blood · 2008 · 203 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10